Company news
Chunghwa Chemical Synthesis & Biotech Co., Ltd. news
Latest news releases, newest first.
The board of directors approved the appointment of the general manager.
August 9, 2022
Chunghwa Chemical Synthesis & Biotech Announce the company's 2022Q2 consolidated financial reports approved by the board of directors.
August 9, 2022
Announcement of the change of the general manager
August 1, 2022
Announcement of the change of Spokesperson, Acting spokesperson.
June 28, 2022
The board of directors resolved the ex-dividend record date of dividend distribution.
June 28, 2022
Announcement of Key Resolutions of CCSB 2022 Annual General Shareholders' Meeting.
May 25, 2022
Announcement of election result of Directors (including independent directors).
May 25, 2022
Chunghwa Chemical Synthesis & Biotech: Approved to release non-compete restrictions on newly elected directors and authorized representatives.
May 25, 2022
Announcement of members change of Audit Committee.
May 25, 2022
The Board of Directors resolved to appoint the 5th Term Remuneration Committee member.
May 25, 2022
Reelection of the company chairman.
May 25, 2022
Update private placement area-within two days from the date of the resolution of board of directors (private placement conversion of corporate bonds)
April 20, 2022
Amendment of the issuance conditions for private placement of domestic convertible corporate bonds including secured or unsecured convertible corporate bonds
April 20, 2022
The board of directors of the company has resolved to conduct private placement of ordinary shares
March 8, 2022
Chunghwa Chemical Synthesis & Biotech: The board of directors of CCSB has resolved to handle private placement of domestic convertible corporate bonds (including secured or unsecured)
March 8, 2022
The Board of Directors Resolved to Distribute Dividend.
March 8, 2022
Resolution of the Board of Directors for convening the 2022 Annual General Shareholders' Meeting. (Adding Matters for Discussion)
March 8, 2022